These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30539771)

  • 1. Dynamic prediction of transition to psychosis using joint modelling.
    Yuen HP; Mackinnon A; Hartmann J; Amminger GP; Markulev C; Lavoie S; Schäfer MR; Polari A; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger G; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; McGorry PD; Nelson B
    Schizophr Res; 2018 Dec; 202():333-340. PubMed ID: 30539771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic prediction systems of transition to psychosis using joint modelling: extensions to the base system.
    Yuen HP; Mackinnon A; Nelson B
    Schizophr Res; 2020 Feb; 216():207-212. PubMed ID: 31839554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
    Ruhrmann S; Schultze-Lutter F; Salokangas RK; Heinimaa M; Linszen D; Dingemans P; Birchwood M; Patterson P; Juckel G; Heinz A; Morrison A; Lewis S; von Reventlow HG; Klosterkötter J
    Arch Gen Psychiatry; 2010 Mar; 67(3):241-51. PubMed ID: 20194824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people.
    Yung AR; Stanford C; Cosgrave E; Killackey E; Phillips L; Nelson B; McGorry PD
    Schizophr Res; 2006 May; 84(1):57-66. PubMed ID: 16630707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population.
    Polari A; Yuen HP; Amminger P; Berger G; Chen E; deHaan L; Hartmann J; Markulev C; McGorry P; Nieman D; Nordentoft M; Riecher-Rössler A; Smesny S; Stratford J; Verma S; Yung A; Lavoie S; Nelson B
    Early Interv Psychiatry; 2021 Jun; 15(3):642-651. PubMed ID: 32558302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Dynamic Risk Prediction Model to Forecast Psychosis Onset in Patients at Clinical High Risk.
    Studerus E; Beck K; Fusar-Poli P; Riecher-Rössler A
    Schizophr Bull; 2020 Feb; 46(2):252-260. PubMed ID: 31355885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders.
    Ising HK; Ruhrmann S; Burger NA; Rietdijk J; Dragt S; Klaassen RM; van den Berg DP; Nieman DH; Boonstra N; Linszen DH; Wunderink L; Smit F; Veling W; van der Gaag M
    Psychol Med; 2016 Jul; 46(9):1839-51. PubMed ID: 26979398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
    Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
    JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JT; Mensink AJ; Bour LJ; van der Meer JN; van Amelsvoort TA; Linszen DH; de Haan L
    World J Biol Psychiatry; 2015 Jan; 16(1):12-21. PubMed ID: 22730901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental factors and social adjustment as predictors of a first psychosis in subjects at ultra high risk.
    Dragt S; Nieman DH; Veltman D; Becker HE; van de Fliert R; de Haan L; Linszen DH
    Schizophr Res; 2011 Jan; 125(1):69-76. PubMed ID: 20884179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Brewer WJ; Spiliotacopoulos D; Bruxner A; Broussard C; Pantelis C; Yung AR
    Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does specific psychopathology predict development of psychosis in ultra high-risk (UHR) patients?
    Thompson A; Nelson B; Bruxner A; O'Connor K; Mossaheb N; Simmons MB; Yung A
    Aust N Z J Psychiatry; 2013 Apr; 47(4):380-90. PubMed ID: 23399857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative symptomatic differences in individuals at Ultra-High Risk for psychosis and healthy controls.
    Velthorst E; Derks EM; Schothorst P; Becker H; Durston S; Ziermans T; Nieman DH; de Haan L
    Psychiatry Res; 2013 Dec; 210(2):432-7. PubMed ID: 23938166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method for analysing transition to psychosis: Joint modelling of time-to-event outcome with time-dependent predictors.
    Yuen HP; Mackinnon A; Nelson B
    Int J Methods Psychiatr Res; 2018 Mar; 27(1):. PubMed ID: 28944523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.